Mefatinib

• Description :

  Mefatinib is a potent tyrosine kinase inhibitor with antineoplastic activity[1].

• Product Name Alternative :

  Mifanertinib (dimaleate)

• UNSPSC :

  12352005

• Target :

  C-Met/HGFR

• Type :

  Reference compound

• Related Pathways :

  Protein Tyrosine Kinase/RTK

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/mefatinib.html

• Purity :

  98.90

• Solubility :

  H2O : 100 mg/mL (ultrasonic)

• Smiles :

  OC(/C=C\C(O)=O)=O.O=C(NC1=CC2=C(NC3=CC=C(C(Cl)=C3)F)N=CN=C2C=C1OC(F)F)/C=C/CN(C)C.OC(/C=C\C(O)=O)=O

• Molecular Formula :

  C29H27ClF3N5O10

• Molecular Weight :

  698.00

• References & Citations :

  [1]WHO Drug Information-World Health Organization (WHO) .

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  4°C (Powder, sealed storage, away from moisture)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1989592-50-8]